Skip to main content
OpenTrials

Clinical trial condition

Clear Cell Renal Cell Carcinoma

Explore clinical trials studying Clear Cell Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.

111 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Clear Cell Renal Cell Carcinoma trial results

Completed

CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)

NCT03163667

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Los Angeles Hematology Oncology Medical Group Los Angeles, California, United States
  • UCLA Department of Medicine - Hematology/Oncology Los Angeles, California, United States
View all 38 locations
View Trial Details
Completed

A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies

NCT02118337

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Overland Park, Kansas, United States
  • Research Site Louisville, Kentucky, United States
View all 27 locations
View Trial Details

Related conditions